Mahdavi M - Search Results

1

Novel Pyrano[3,2-c]quinoline-1,2,3-triazole Hybrids as Potential Anti-Diabetic Agents: In Vitro α-Glucosidase Inhibition, Kinetic, and Molecular Dynamics Simulation.

Esmaili S, Ebadi A, Khazaei A, Ghorbani H, Faramarzi MA, Mojtabavi S, Mahdavi M, Najafi Z. Esmaili S, et al. Among authors: mahdavi m. ACS Omega. 2023 Jun 20;8(26):23412-23424. doi: 10.1021/acsomega.3c00133. eCollection 2023 Jul 4. ACS Omega. 2023. PMID: 37426262 Free PMC article.

2

Synthesis and Biological Investigation of some Novel Sulfonamide and Amide Derivatives Containing Coumarin Moieties.

Saeedi M, Goli F, Mahdavi M, Dehghan G, Faramarzi MA, Foroumadi A, Shafiee A. Saeedi M, et al. Among authors: mahdavi m. Iran J Pharm Res. 2014 Summer;13(3):881-92. Iran J Pharm Res. 2014. PMID: 25276188 Free PMC article.

3

Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.

Najafi Z, Saeedi M, Mahdavi M, Sabourian R, Khanavi M, Tehrani MB, Moghadam FH, Edraki N, Karimpor-Razkenari E, Sharifzadeh M, Foroumadi A, Shafiee A, Akbarzadeh T. Najafi Z, et al. Among authors: mahdavi m. Bioorg Chem. 2016 Aug;67:84-94. doi: 10.1016/j.bioorg.2016.06.001. Epub 2016 Jun 2. Bioorg Chem. 2016. PMID: 27289559

4

Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.

Najafi Z, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Asatouri R, Vafadarnejad F, Moghadam FH, Khanavi M, Sharifzadeh M, Akbarzadeh T. Najafi Z, et al. Among authors: mahdavi m. Eur J Med Chem. 2017 Jan 5;125:1200-1212. doi: 10.1016/j.ejmech.2016.11.008. Epub 2016 Nov 8. Eur J Med Chem. 2017. PMID: 27863370

5

Novel Tacrine-Based Pyrano[3',4':5,6]pyrano[2,3-b]quinolinones: Synthesis and Cholinesterase Inhibitory Activity.

Hariri R, Afshar Z, Mahdavi M, Safavi M, Saeedi M, Najafi Z, Sabourian R, Karimpour-Razkenari E, Edraki N, Moghadam FH, Shafiee A, Khanavi M, Akbarzadeh T. Hariri R, et al. Among authors: mahdavi m. Arch Pharm (Weinheim). 2016 Dec;349(12):915-924. doi: 10.1002/ardp.201600123. Epub 2016 Nov 7. Arch Pharm (Weinheim). 2016. PMID: 27910192

6

Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.

Nikookar H, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Ranjbar PR, Mahdavi M, Larijani B. Nikookar H, et al. Among authors: mahdavi m. Bioorg Chem. 2018 Apr;77:280-286. doi: 10.1016/j.bioorg.2018.01.025. Epub 2018 Feb 3. Bioorg Chem. 2018. PMID: 29421703

7

Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.

Heydari Z, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Mahdavi M, Ranjbar PR, Larijani B. Heydari Z, et al. Among authors: mahdavi m. Med Chem. 2019;15(1):8-16. doi: 10.2174/1573406414666180528110104. Med Chem. 2019. PMID: 29807519 Review.

8

New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.

Adib M, Peytam F, Rahmanian-Jazi M, Mahernia S, Bijanzadeh HR, Jahani M, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Mahdavi M, Larijani B. Adib M, et al. Among authors: mahdavi m. Eur J Med Chem. 2018 Jul 15;155:353-363. doi: 10.1016/j.ejmech.2018.05.046. Epub 2018 May 29. Eur J Med Chem. 2018. PMID: 29902721

9

Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.

Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B. Mohammadi-Khanaposhtani M, et al. Among authors: mahdavi m. Bioorg Chem. 2018 Oct;80:288-295. doi: 10.1016/j.bioorg.2018.06.035. Epub 2018 Jun 30. Bioorg Chem. 2018. PMID: 29980114

10

Biology-Oriented Drug Synthesis (BIODS) Approach towards Synthesis of Ciprofloxacin-Dithiocarbamate Hybrids and Their Antibacterial Potential both in Vitro and in Silico.

Esfahani EN, Mohammadi-Khanaposhtani M, Rezaei Z, Valizadeh Y, Rajabnia R, Bagheri M, Bandarian F, Faramarzi MA, Samadi N, Amini MR, Mahdavi M, Larijani B. Esfahani EN, et al. Among authors: mahdavi m. Chem Biodivers. 2018 Oct;15(10):e1800273. doi: 10.1002/cbdv.201800273. Epub 2018 Sep 24. Chem Biodivers. 2018. PMID: 30019534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

797 results

Search Page